Metraipolis › archive › dc_7519e2f08a2f
Darbepoetin alfa for the treatment of anemia in myelodysplastic syndromes: a post-marketing surveillance study in Japan — Europe PMC PMID:42151711
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42151711
- DOI
- 10.1007/s12185-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T13:52:57.561Z
- SHA-256 of the archived text
17e3ee217ed9d82ac4a95f9f76296fc5cde802295f6d73b1c4351e77f321c9e0- Stable URL of this page
https://metraipolis.com/documento/dc_7519e2f08a2f
How to cite
Darbepoetin alfa for the treatment of anemia in myelodysplastic syndromes: a post-marketing surveillance study in Japan — Europe PMC PMID:42151711 — Europe PMC (en), https://europepmc.org/article/MED/42151711 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7519e2f08a2f (Metraipolis archive dc_7519e2f08a2f, sha256 17e3ee217ed9d82ac4a95f9f76296fc5cde802295f6d73b1c4351e77f321c9e0)
BibTeX
@misc{dc7519e2f08a2f,
title = {Darbepoetin alfa for the treatment of anemia in myelodysplastic syndromes: a post-marketing surveillance study in Japan — Europe PMC PMID:42151711},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42151711},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7519e2f08a2f; sha256 17e3ee217ed9d82ac4a95f9f76296fc5cde802295f6d73b1c4351e77f321c9e0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42151711. Agents can read the archived copy with the MCP tool read_document.